LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia

• Kristen Sweet,
• Cathye Shu,
• Irina Murakhovskaya,
• Bruno Fattizzo,
• Tarek Ebrahim,
• YoungJa Lee

Affiliations

Kristen Sweet

5Immunology, Janssen Research and Development, LLC, USA

Cathye Shu

5Immunology, Janssen Research and Development, LLC, USA

Irina Murakhovskaya

1Department of Hematology and Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, USA

Bruno Fattizzo

2Hematology Unit, Fondazione IRCCS Ca’Granda Ospedale Maggiore Plicilinico, Italy

Tarek Ebrahim

3Immunology, Janssen Pharmaceutical Companies of Johnson and Johnson, USA

YoungJa Lee

3Immunology, Janssen Asia Pacific, Republic of Korea